Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor

Anticancer composition comprising tumor-specific oncolytic adenovirus and immune checkpoint inhibitor

US Patent 11364272 · Granted Jun 21, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PH-sensitive and bioreducible polymer-virus complex for cancer treatment2024
Recombinant adenoviruses and stem cells comprising same2023
Adenovirus complex for gene delivery and gene iherapy2022
Ph-sensitive and bioreducible polymer-virus complex for cancer treatment2021
Virus-PCION complex having enhanced antitumor effect by using electromagnetic fi2021
Composition for preventing or treating keloid or hypertrophic scars2020
Complex of adenovirus and PAMAM-PEG-Erbitux, and use thereof2020
Composition for intracellular delivery containing adenovirus protein VI-derived 2020
Peptide having anticancer activity, and pharmaceutical composition and dietary s2020
Virus-PCION complex having enhanced antitumor effect by using electromagnetic fi2019
Conditionally replicating adenovirus to express REIC gene2018
Decorin gene delivery system and cancer treatment2018